Loading organizations...
Loading organizations...
Biopharmaceutical company improving outcomes in oncologic and neurologic di
Immuneering has raised $82.0M across 2 funding rounds.
Immuneering has raised $82.0M in total across 2 funding rounds.
Immuneering has raised $82.0M in total across 2 funding rounds.
Immuneering's investors include Andrew Phillips, BlackRock, LYFE Capital, Perceptive Advisors, Rock Springs Capital, Surveyor Capital, T. Rowe Price Associates, Joseph Kekst.
Immuneering has raised $82.0M across 2 funding rounds. Most recently, it raised $62.0M Series B in January 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 5, 2021 | $62.0M Series B | Andrew Phillips | BlackRock, LYFE Capital, Perceptive Advisors, Rock Springs Capital, Surveyor Capital, T. Rowe Price Associates |
| Jan 22, 2020 | $20.0M Series A | Joseph Kekst |